Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Oct 15, 2026; 18(10): 120941
Published online Oct 15, 2026. doi: 10.4251/wjgo.120941
Published online Oct 15, 2026. doi: 10.4251/wjgo.120941
Figure 4 miR-4770 regulates the viability, migration and invasion of HCT116 cells through PRKAA2.
A: QRT-PCR was used to detect the mRNA expression of PRKAA2 in siNC group and si-PRKAA2 group; B: CCK-8 method was used to detect the proliferation activity of four groups of cells at 24 hours, 48 hours and 72 hours: NC inhibitor + siNC, miR inhibitor + siNC, NC inhibitor + si-PRKAA2, miR inhibitor + si-PRKAA2; C and D: Transwell assay was used to evaluate the migration (C) and invasion (D) abilities of the above four groups of cells. Scale: 100 μm. The data are expressed as mean ± SD and are derived from three independent biological replicates. aP < 0.01 vs siNC group; bP < 0.05 and cP < 0.01 vs NC inhibitor + siNC group; dP < 0.05 and eP < 0.01 vs miR inhibitor + siNC group; fP < 0.05 and gP < 0.01 vs NC inhibitor + si-PRKAA2 group.
- Citation: Yi BS, Lai HB. miR-4770 promotes colorectal cancer progression by targeting PRKAA2 via m6A modification. World J Gastrointest Oncol 2026; 18(10): 120941
- URL: https://www.wjgnet.com/1948-5204/full/v18/i10/120941.htm
- DOI: https://dx.doi.org/10.4251/wjgo.120941